Amazon Expands AI Shopping Technology to Retail Partners Signs Kate Spade as First Customer
US Retail Sales Show Resilience Amid Persistent Cost Pressures ING Analysis
PNC Infratech Could See Significant Upside as Brokerages Highlight Growth Drivers After Q4 Results
Plus500 Revenue Rises 11 in Latest Quarter Company Expects to Meet FullYear Targets
Vestas Wind Systems Shares Decline After Margins Guidance Disappoints
BP Chairman Abruptly Removed Amid Reports of Bullying and Overbearing Conduct
MUFG Q1 2026 Earnings Strong EPS Beat Amid Cautious Market Sentiment
MGPI Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiencies
Mobile Infrastructure Corporation BEEP Q1 2026 Earnings NarrowerThanExpected Loss Despite Stock Decline
AVXL Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances
APH Q1 2026 Earnings EPS Surges Past Estimates Signaling Strong Operational Momentum
DGICA Q1 2026 Earnings EPS Misses Estimates Stock Declines
Watts Water Technologies WTS Edges Higher Amid Steady Demand and Industrial Trends
Beazer Homes BZH Sees Uptick as Market Tests Key Resistance Near 2558
CIT Inc CINT Edges Higher Navigating Key Support and Resistance Levels
Hall Chadwick Acquisition Corp Rights HCACR Holds Steady at 029 Sideways Action in a Tight Range
Morgan Stanley Emerging Markets Domestic Debt Fund EDD Rises 11 as Emerging Market Debt Shows Resilience
GSRF GSR IV Acquisition Corp Holds Steady at 1013 as Consolidation Defines the Session
National Fuel Gas NFG Edges Lower Maintains Position Above Key Support
TPG Mortgage Investment Trust MITT Gains 17 as Mortgage REIT Sector Sees Renewed Interest
Offerpad Solutions OPAD Edges Higher as Stock Tests Key Resistance Zone
SenesTech Inc SNES Edges Higher Approaching Key Resistance at 190
PowerBank Corporation SUUN Slips Marginally as Traders Eye Key Support at 098
Dhoot Transmission Files Updated DRHP for 1400 Crore IPO with Sebi
BioCardia Inc BCDA Q1 2026 Earnings WiderthanExpected Loss as PreRevenue ClinicalStage Firm Advances Trials
Recursion Pharmaceuticals RXRX Slips 13 as Biotech Stock Tests Key Support Near 282